Prevail Therapeutics are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders. 

Biotechnology

Prevail Therapeutics

Franz Hefti

Sid K.

Jeffrey Sevigny

Mansuo Lu Shannon

The Scientific Research and Development team at Prevail Therapeutics is dedicated to discovering and developing innovative gene therapies that target the genetic causes of Parkinson's disease and other neurodegenerative disorders. This team conducts cutting-edge research, performs preclinical studies, and advances the understanding of disease mechanisms to drive the development of effective gene therapy treatments.

Scientific Research and Development

About

Team members

Other teams at Prevail Therapeutics

Leadership Team